Glycopyrrolate injection - Exela Pharma Sciences
Alternative Names: GLYRX PFLatest Information Update: 02 Oct 2021
At a glance
- Originator Exela Pharma Sciences
- Class Antiasthmatics; Antispasmodics; Antiulcers; Pyrrolidines; Quaternary ammonium compounds; Skin disorder therapies; Small molecules
- Mechanism of Action Cholinergic receptor antagonists; Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Anaesthesia; Peptic ulcer